Multiple Sclerosis, Primary Progressive research hub
3 indexed studies · 0 currently recruiting
- active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
This study is comparing two medicines, fenebrutinib and ocrelizumab, to see which is safer and better at slowing down primary progressive multiple sclerosis (PPMS). It's for adults with PPMS and aims to understand how these treatments affect the disease progression.
United States · Argentina · Australia - active not recruitingNA
Cognition Evolution and MRI Markers in PPMS Patients on 2 Years
This study looks at how thinking and memory skills change over two years in people with primary progressive multiple sclerosis (PPMS). It uses special brain scans (MRI) to understand these changes better and how they compare to healthy people.
France - active not recruitingPHASE3
A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
This study is looking at a new treatment called Ocrelizumab for primary progressive multiple sclerosis (PPMS). It compares Ocrelizumab to a dummy drug (placebo) to see how safe and effective it is for adults, including those who have had PPMS for a while.
United States · Australia · Belgium